| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EW | Common Stock | Options Exercise | $338K | +7.46K | +12.63% | $45.28 | 66.5K | Mar 10, 2025 | Direct | F1 |
| transaction | EW | Common Stock | Gift | $0 | -1.3K | -1.95% | $0.00 | 65.2K | Mar 10, 2025 | Direct | |
| transaction | EW | Common Stock | Sale | -$428K | -6.16K | -9.45% | $69.51 | 59.1K | Mar 10, 2025 | Direct | F1, F2 |
| transaction | EW | Common Stock | Gift | $0 | +1.3K | +14.22% | $0.00 | 10.4K | Mar 10, 2025 | By Trust | |
| holding | EW | Common Stock | 3.5K | Mar 10, 2025 | 401(k) | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EW | Employee Stock Option (Right to Acquire) | Options Exercise | $0 | -7.46K | -50% | $0.00 | 7.46K | Mar 10, 2025 | Common Stock | 7.46K | $45.28 | Direct | F4 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024. |
| F2 | This transaction was executed in multiple trades at prices ranging from $69.41 to $69.64 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator. |
| F4 | These options were granted on May 17, 2018 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one yearafter the grant date in four equal annual installments. |
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.